Skip to main content

BioServe Acquires Genomics Collaborative From SeraCare Life Sciences

NEW YORK (GenomeWeb News) — BioServe today said it has acquired Genomics Collaborative from SeraCare Life Sciences for an undisclosed sum.
Genomics Collaborative offers access to a repository of 600,000 human DNA, tissue and serum samples that are “linked to detailed clinical and demographic data from 140,000 consented and anonymized patients collected on four continents, BioServe said.
BioServe said it will “fully” integrate Genomics Collaborative into its operations.
Bioserve said the acquisition “significantly expands” its pre-clinical service offerings and for drug discovery and development, allowing the company to offer a platform that takes “biomaterial to validated data.”
The combined platform will include DNA and RNA purification reagents, DNA sequencing, oligonucleotide synthesis, and genotyping services for studies of a variety of diseases, including cardiovascular disease, inflammatory disorders, several common cancers, and others.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.